Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of KRN125 (pegfilgrastim) for mobilization of hematopoietic stem cells in healthy volunteers
jRCT2080224699Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- May 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of pegfilgrastim, sponsored by Kyowa Kirin. Started May 2019; status: completed.
02
Drugs
pegfilgrastim
Beyond the preview
Go deeper on jRCT2080224699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224699.